Stay cool with the latest edition of "Weekly Update!" We have not one but two STAT investigations - plus, biotech updates, Fauci on the First Opinion podcast, Elmo and friends, and much more! Read now ⬇
STAT
Internet News
Boston, Massachusetts 31,571 followers
Reporting from the frontiers of health and medicine.
About us
Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: http://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews
- Website
-
http://www.statnews.com
External link for STAT
- Industry
- Internet News
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Specialties
- news, science news, medicine, health, biotech, pharma, health tech, covid, hospitals, and business
Locations
-
Primary
1 Exchange Pl
Boston, Massachusetts 02109, US
Employees at STAT
Updates
-
A new paper suggests one way to crack down on patent system abuses by the drug industry: Fix a little-known method for correcting mistakes that lengthen the life of a patent. https://trib.al/AZLnxoa
U.S. Patent Office software mistakes extend patent life for drugs and need to be fixed, researchers say
https://www.statnews.com
-
The hearing keeps attention on PBM reforms as Congress nears the so-called "lame duck period" that might be an opportune time to pass a big health care legislative package. https://trib.al/SRYOtQs
House hearing keeps pressure on PBM practices while Congress considers reforms
https://www.statnews.com
-
Sen. J.D. Vance has a history of investing in health care companies — and of pursuing health care policies that are sometimes at odds with his party’s base. Here's what we know: https://trib.al/RQf5Er8
-
STAT reposted this
When Sanjaya Singh left Johnson & Johnson in 2021, his former colleague Peter Lebowitz paid close attention. “If Sanjaya Singh is doing something, you want to watch it,” Lebowitz said. That new venture, Philadelphia-based Third Arc Bio, launched Tuesday with $165 million from a Series A round led by Vida Ventures and co-led by Cormorant Asset Management, LP and Hillhouse Investment. The money will go toward developing T-cell engagers for cancer and autoimmune diseases. What do you think are the best approaches for autoimmune disease drug development? And which friend or colleague would you follow to a new job? #biotech #pharma #startup #seriesA #venturecapital #fundraising #cancer #oncology #autoimmune #drugdevelopment #Tcell #immunotherapy STAT
Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies
https://www.statnews.com
-
The CDC’s Advisory Committee on Immunization Practices is considering changes to the adolescent meningococcal vaccination schedule that could impact immunization policies. Join STAT Brand Studio along with speakers Richard Hughes IV, Will Humble, and advocate Leslie Maier for insights: https://trib.al/gMecik1 #STATBrandStudio
-
-
A Biden administration proposal to loosen federal restrictions on marijuana is dividing some of the nation’s top medical professionals. https://trib.al/jdmnxJn
Medical groups are divided over Biden plan to loosen DEA restrictions on marijuana
https://www.statnews.com
-
“Plan sponsors and policymakers would be wise to learn and leverage these findings to ensure PBMs are in fact holding up their end of the bargain to lower drug costs, not inflate them,” said Antonio Ciaccia, a former pharmacy lobbyist who is the CEO and co-founder of 46brooklyn, a group that studies pharmaceutical pricing.. #pharma #medicines #pharmacy #pbm #rebates #postoffice #postalservice #gpo #expressscripts #cigna
Express Scripts overcharged postal workers by $45 million, audit says
https://www.statnews.com
-
Opinion: Drug-device equity is needed to support medical device innovation, industry investment and patient access to safe and effective new treatments. https://trib.al/3t3EAXt
Fixing the reimbursement and coverage divide between 'breakthrough' drugs and medical devices
https://www.statnews.com
-
Third Arc Bio, led by J&J veterans, launches with $165 million to develop cancer and autoimmune therapies. https://trib.al/G51j8Td
Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies
https://www.statnews.com